Overview

Intranasal Insulin for Posttraumatic Stress Disorder

Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
To evaluate if intranasal insulin is effective in reducing PTSD symptoms.
Phase:
Phase 2
Details
Lead Sponsor:
VA Connecticut Healthcare System
Treatments:
Insulin
Insulin, Globin Zinc